28 related articles for article (PubMed ID: 38595589)
1. Salivary and Serum Interleukin-6: A Credible Marker for Predicting Oral Leukoplakia and Oral Squamous Cell Carcinoma by Enzyme-Linked Immunosorbent Assay (ELISA).
Oshin M; Kulkarni PG; D SPR; Deepthi G; S KS; S JK
Cureus; 2024 Apr; 16(4):e59113. PubMed ID: 38803729
[TBL] [Abstract][Full Text] [Related]
2. Differences in modifiable factors of oral squamous cell carcinoma in the upper and lower of oral fissure.
Yan L; Chen F; Liu F; Qiu Y; Wang J; Wu J; Bao X; Hu Z; Peng X; Lin X; Cai L; Lin L; He B
Oncotarget; 2017 Sep; 8(43):75094-75101. PubMed ID: 29088848
[TBL] [Abstract][Full Text] [Related]
3. Histological pattern of tumor inflammation and stromal density correlate with patient demographics and immuno-oncologic transcriptional profile in oral squamous cell carcinoma.
Theofilou VI; Ghita I; Elnaggar M; Chaisuparat R; Papadimitriou JC; Bentzen SM; Dyalram D; Lubek JE; Ord RA; Younis RH
Front Oral Health; 2024; 5():1408072. PubMed ID: 38903181
[TBL] [Abstract][Full Text] [Related]
4. Expanding salivary biomarker detection by creating a synthetic neuraminic acid sensor via chimeragenesis.
Verzino SJ; Priyev SA; Sánchez Estrada VA; Crowley GX; Rutkowski A; Lam AC; Nazginov ES; Kotemelo P; Bacelo A; Sukhram DT; Vázquez FX; Juárez JF
bioRxiv; 2024 Jun; ():. PubMed ID: 38915506
[TBL] [Abstract][Full Text] [Related]
5. Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head/neck squamous cell carcinoma (HNSCC): A systematic review and network meta-analysis.
Khijmatgar S; Yong J; Rübsamen N; Lorusso F; Rai P; Cenzato N; Gaffuri F; Del Fabbro M; Tartaglia GM
Jpn Dent Sci Rev; 2024 Dec; 60():32-39. PubMed ID: 38204964
[TBL] [Abstract][Full Text] [Related]
6. Salivary Interleukin-1 Levels in Oral Squamous Cell Carcinoma: A Case-Control Study.
Vala D; Shah J; Purba AK; Mehta T; Mansata AV; Almalki SA; Makkad RS
J Pharm Bioallied Sci; 2024 Feb; 16(Suppl 1):S346-S348. PubMed ID: 38595589
[TBL] [Abstract][Full Text] [Related]
7. Salivary Immunosuppressive Cytokines IL-10 and IL-13 Are Significantly Elevated in Oral Squamous Cell Carcinoma Patients.
Aziz S; Ahmed SS; Ali A; Khan FA; Zulfiqar G; Iqbal J; Khan AA; Shoaib M
Cancer Invest; 2015; 33(7):318-28. PubMed ID: 26046681
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Salivary Interleukin-6 in Patients with Oral Squamous Cell Carcinoma, Oral Potentially Malignant Disorders, Chronic Periodontitis and in Healthy Controls - A Cross-Sectional Comparative Study.
Rani NAJ; Vardhan BGH; Srinivasan S; Gopal SK
Ann Maxillofac Surg; 2023; 13(1):70-75. PubMed ID: 37711518
[TBL] [Abstract][Full Text] [Related]
9. Salivary interleukin-6 and -8 in patients with oral cancer and patients with chronic oral inflammatory diseases.
Lisa Cheng YS; Jordan L; Gorugantula LM; Schneiderman E; Chen HS; Rees T
J Periodontol; 2014 Jul; 85(7):956-65. PubMed ID: 24147842
[TBL] [Abstract][Full Text] [Related]
10. Chronic periodontitis can affect the levels of potential oral cancer salivary mRNA biomarkers.
Cheng YL; Jordan L; Chen HS; Kang D; Oxford L; Plemons J; Parks H; Rees T
J Periodontal Res; 2017 Jun; 52(3):428-437. PubMed ID: 27549383
[TBL] [Abstract][Full Text] [Related]
11. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
12. Detection of Human PapillomaVirus and its Association with Potentially Malignant Disorders and Oral Squamous Cell Carcinoma: A Retrospective Study.
Rathore A; Tiwari A; Nazim M; Gupta AK; Gande M; Krishnakumar J
J Pharm Bioallied Sci; 2022 Jul; 14(Suppl 1):S820-S824. PubMed ID: 36110657
[TBL] [Abstract][Full Text] [Related]
13. Oral cancer: Etiology and risk factors: A review.
Kumar M; Nanavati R; Modi TG; Dobariya C
J Cancer Res Ther; 2016; 12(2):458-63. PubMed ID: 27461593
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.
Dinarello CA
Blood; 2011 Apr; 117(14):3720-32. PubMed ID: 21304099
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
